Bessemer Group Inc Seagen Inc. Transaction History

Bessemer Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $38,302 - $43,232	-200 Reduced 12.55%	1,394 $296,000
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $257,066 - $282,562	1,370 Added 611.61%	1,594 $307,000
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $43,896 - $52,049	-374 Reduced 62.54%	224 $29,000
Q3 2022 Nov 09, 2022	SELL	$135.27 - $180.11 $1,352 - $1,801	-10 Reduced 1.64%	598 $82,000
Q2 2022 Aug 10, 2022	BUY	$108.81 - $179.33 $1,088 - $1,793	10 Added 1.67%	608 $108,000

Q4 2021 Jan 27, 2022	BUY	$142.57 - $190.86 $85,256 - $114,134	598 New	598 $92,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.